Published by Josh White on 12th August 2020
(Sharecast News) - Shares in N4 Pharma rocketed on Wednesday, after it announced that 'Nuvec' loaded with coronavirus plasmid had successfully transfected human embryonic kidney (HEK) cells in vitro, and induced an expression of the spike protein in the cells.
URL: http://www.digitallook.com/dl/news/story/31048634/...